| Kwality Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 539997 |
NSE Symbol : - |
P/E(TTM) : 27.16 |
|
ISIN Demat : INE552U01010 |
Div & Yield% : - |
EPS(TTM) : 33.16 |
|
Book Value(₹) : 233.22 |
Market Cap(₹Cr) : 934.53 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 90.03 | 80.08 | 91.98 | 78.10 | 69.65 | 67.45 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 90.03 | 80.08 | 91.98 | 78.10 | 69.65 | 67.45 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.22 | 0.28 | 0.58 | 0.62 | 0.23 | 0.40 |
| Total Income | 90.26 | 80.36 | 92.56 | 78.71 | 69.88 | 67.85 |
| Total Expenditure | 70.35 | 62.72 | 78.22 | 61.39 | 54.38 | 53.64 |
| PBIDT | 19.90 | 17.63 | 14.34 | 17.32 | 15.50 | 14.20 |
| Interest | 2.71 | 2.48 | 3.06 | 2.73 | 2.41 | 2.19 |
| PBDT | 17.20 | 15.16 | 11.29 | 14.59 | 13.09 | 12.02 |
| Depreciation | 4.61 | 4.02 | 5.04 | 4.81 | 4.88 | 4.78 |
| Tax | 4.07 | 2.80 | 1.57 | 2.46 | 2.15 | 1.82 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.03 | -0.03 | 0.18 | -0.39 | -0.20 | -0.03 |
| Reported Profit After Tax | 8.49 | 8.37 | 4.50 | 7.70 | 6.26 | 5.45 |
| Extra-ordinary Items | 0.00 | 0.00 | -5.35 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 8.49 | 8.37 | 9.85 | 7.70 | 6.26 | 5.45 |
| EPS (Unit Curr.) | 8.18 | 8.06 | 4.33 | 7.42 | 6.03 | 5.17 |
| EPS (Adj) (Unit Curr.) | 8.18 | 8.06 | 4.33 | 7.42 | 6.03 | 5.17 |
| Calculated EPS (Unit Curr.) | 8.18 | 8.06 | 4.33 | 7.42 | 6.03 | 5.25 |
| Calculated EPS (Adj) (Unit Curr.) | 8.18 | 8.06 | 4.33 | 7.42 | 6.03 | 5.25 |
| Calculated EPS (Ann.) (Unit Curr.) | 32.71 | 32.25 | 17.33 | 29.69 | 24.12 | 20.99 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 32.71 | 32.25 | 17.33 | 29.69 | 24.12 | 20.99 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 22.10 | 22.02 | 15.59 | 22.18 | 22.25 | 21.05 |
| PBDTM(%) | 19.10 | 18.93 | 12.27 | 18.68 | 18.79 | 17.82 |
| PATM(%) | 9.43 | 10.45 | 4.89 | 9.86 | 8.99 | 8.08 |